Japan Lifeline Co Ltd
TSE:7575

Watchlist Manager
Japan Lifeline Co Ltd Logo
Japan Lifeline Co Ltd
TSE:7575
Watchlist
Price: 1 313 JPY 1.31% Market Closed
Market Cap: 92B JPY
Have any thoughts about
Japan Lifeline Co Ltd?
Write Note

Japan Lifeline Co Ltd
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Japan Lifeline Co Ltd
Cash from Financing Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Japan Lifeline Co Ltd
TSE:7575
Cash from Financing Activities
-ÂĄ8.6B
CAGR 3-Years
-32%
CAGR 5-Years
-37%
CAGR 10-Years
N/A
Terumo Corp
TSE:4543
Cash from Financing Activities
-ÂĄ97.5B
CAGR 3-Years
-7%
CAGR 5-Years
-7%
CAGR 10-Years
-16%
Olympus Corp
TSE:7733
Cash from Financing Activities
-ÂĄ327.6B
CAGR 3-Years
-44%
CAGR 5-Years
-31%
CAGR 10-Years
-23%
Sysmex Corp
TSE:6869
Cash from Financing Activities
-ÂĄ6.7B
CAGR 3-Years
31%
CAGR 5-Years
17%
CAGR 10-Years
-3%
Nihon Kohden Corp
TSE:6849
Cash from Financing Activities
-ÂĄ6.1B
CAGR 3-Years
1%
CAGR 5-Years
-15%
CAGR 10-Years
-5%
JEOL Ltd
TSE:6951
Cash from Financing Activities
-ÂĄ3.7B
CAGR 3-Years
N/A
CAGR 5-Years
-6%
CAGR 10-Years
-13%
No Stocks Found

Japan Lifeline Co Ltd
Glance View

Market Cap
91.8B JPY
Industry
Health Care

Japan Lifeline Co., Ltd. engages in the import, development, production, and distribution of medical devices. The company is headquartered in Shinagawa-Ku, Tokyo-To and currently employs 1,167 full-time employees. The firm is mainly engaged in the production of rhythm devices, electrophysiological (EP) and ablations, surgical products and intervention products. The rhythm devices include cardiac pacemakers, implantable cardioverter defibrillator (ICD), cardiac resynchronization therapy defibrillator (CRT-D) and other rhythm devices. The EP and ablations include EP catheters for cardiac arrhythmia examination, ablation catheters for arrhythmia treatment and other EP and ablations. The surgical products include prosthetic heart valves and annuloplasty rings for heart disease surgical treatment, vascular grafts, open stent grafts and stent grafts for aortic disease treatment, as well as other surgical products. The intervention products include balloon catheters, guide wires, penetration catheters and other intervention products.

Intrinsic Value
1 952.45 JPY
Undervaluation 33%
Intrinsic Value
Price

See Also

What is Japan Lifeline Co Ltd's Cash from Financing Activities?
Cash from Financing Activities
-8.6B JPY

Based on the financial report for Jun 30, 2024, Japan Lifeline Co Ltd's Cash from Financing Activities amounts to -8.6B JPY.

What is Japan Lifeline Co Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
-37%

Over the last year, the Cash from Financing Activities growth was -32%. The average annual Cash from Financing Activities growth rates for Japan Lifeline Co Ltd have been -32% over the past three years , -37% over the past five years .

Back to Top